A Study of KC1036 in Adolescents With Advanced Ewing Sarcoma

NCT06564272 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Ewing Sarcoma

Interventions

DRUG: KC1036

Sponsor

Beijing Konruns Pharmaceutical Co., Ltd.